跳至主要内容
临床试验/NCT02550483
NCT02550483已完成不适用

Novel Metabolites of Beta-Carotene and Lycopene

USDA Beltsville Human Nutrition Research Center1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2015年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
36
试验地点
1
主要终点
Change in apocarotenoid concentrations will be measured in blood

研究概览

简要总结

The study (n = 36) will be a parallel design and will be 6 weeks in duration. Participants will start with a 2-week free-living wash-in period where they will be asked to avoid certain carotenoid-rich foods, followed by 4 weeks of a completely controlled diet. In addition to the controlled diet, participants will consume one of three beverages (300 mL/day; n = 12/group): placebo beverage (control), high beta-carotene tomato juice, and high-lycopene tomato juice. Blood, urine and feces will be collected throughout the study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
21 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • 未提供

排除标准

  • •Age less than 21 or greater than 75 years
  • •Glucose > 126 mg/dl
  • •Triglycerides > 300 mg/dl
  • •Known allergy or intolerance to tomatoes or tomato products
  • •Pregnant, lactating, or intend to become pregnant during the study period
  • •History of bariatric surgery or nutrient malabsorption disease (such as celiac disease) or other metabolic disorders requiring special diet recommendations
  • •Smoker or use of tobacco products
  • •Presently have cancer
  • •Use of certain medications (prescription or over-the-counter) that may interfere with the study objectives
  • •Type 2 diabetes
  • •Use of blood-thinning medications such as Coumadin (warfarin), Dicumarol, or Miradon (anisindione)
  • •Unable or unwilling to give informed consent or communicate with study staff
  • •Self-report of alcohol or substance abuse within the past 12 months and/or current acute treatment or rehabilitation program for these problems (long-term participation in Alcoholics Anonymous is not an exclusion)
  • •Other medical, psychiatric, or behavioral factors that in the judgment of the Principal Investigator may interfere with study participation or the ability to follow the intervention protocol

研究组 & 干预措施

Beta-Carotene Tomato Juice

Active Comparator

Participants will receive high beta-carotene tomato juice daily as part of controlled diet (base diet + high beta-carotene tomato juice).

干预措施: Base diet + high beta-carotene tomato juice (Other)

Lycopene Tomato Juice

Active Comparator

Participants will receive high lycopene tomato juice daily as part of controlled diet (base diet + high lycopene tomato juice).

干预措施: Base diet + high lycopene tomato juice (Other)

Placebo Beverage

Placebo Comparator

Participants will receive placebo beverage daily as part of controlled diet (base diet + placebo beverage).

干预措施: Base diet + placebo beverage (Other)

结局指标

主要结局

Change in apocarotenoid concentrations will be measured in blood

时间窗: Baseline, 2 weeks, 4 weeks

Apocarotenoid concentrations will be measured in blood (baseline, after washout; 2 wks; 4 wks).

Change in carotenoid concentrations will be measured in blood

时间窗: Baseline, 2 weeks, 4 weeks

Carotenoid concentrations will be measured in blood (baseline, after washout; 2 wks, 4 wks).

次要结局

  • Identification of unknown urinary carotenoid metabolites(Baseline, 2 weeks, 4 weeks)
  • Change in proportion of phyla of colonic microbiota(Baseline, 4 weeks)
  • Change in global gene expression(Baseline, 4 weeks)

研究者

发起方
USDA Beltsville Human Nutrition Research Center
申办方类型
Fed
责任方
Principal Investigator
主要研究者

Janet Novotny

Research Physiologist

USDA Beltsville Human Nutrition Research Center

研究点 (1)

Loading locations...

相似试验